616 Pharmacokinetics and safety of a subcutaneous formulation of nivolumab (NIVO SC) monotherapy: updated results from the phase 1/2 CheckMate 8KX study

التفاصيل البيبلوغرافية
العنوان: 616 Pharmacokinetics and safety of a subcutaneous formulation of nivolumab (NIVO SC) monotherapy: updated results from the phase 1/2 CheckMate 8KX study
المؤلفون: Lonardi, Sara, Ługowska, Iwona, O’Donnell, Anne, Jackson, Christopher, Latten-Jansen, Loes Maria, North, Richard, Salvo, Marcelo Garrido, Santoro, Armando, Chacón, Matías, Li, Linghui, Joseph, Devanand, Gibson, Elizabeth, Bennett, Bryan, Gurm, Balmeet, Ng, Wee-Teck, Donald Harvey, R, Trigo Pérez, José Manuel, Calvo, Aitana
المصدر: Regular and Young Investigator Award Abstracts
بيانات النشر: BMJ Publishing Group Ltd
سنة النشر: 2023
نوع الوثيقة: conference object
اللغة: unknown
DOI: 10.1136/jitc-2023-sitc2023.0616
DOI: 10.1136/jitc-2023-SITC2023.0616
الإتاحة: https://doi.org/10.1136/jitc-2023-sitc2023.0616Test
حقوق: http://creativecommons.org/licenses/by-nc/4.0Test/
رقم الانضمام: edsbas.EBAA620F
قاعدة البيانات: BASE